By attaching specialised molecules to the backbone of DNA, researchers have made it easier to detect rare molecules associated with early disease.
The presence of, or changes in the concentration of, certain proteins in biological fluids can be indicators of disease. However, in the early stages of disease these ‘biomarkers’ can be difficult to detect, as they are relatively rare.
We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.
– Dr Alex Ivanov
Detecting important biomarkers in lower concentrations will allow patients to be treated earlier for diseases such as some cancers and neurological disorders, which could increase the chance of survival rate.
However, current methods of detection are often not sufficiently sensitive and require costly and time-consuming sample pre-treatment.
Now, researchers from the Department of Chemistry at Imperial College London have come up with a system that is specific, flexible, and can detect single protein biomarkers directly in human serum (a pool of fluid separated from blood).
The system represents a significant innovation, as it is more sensitive to specific biomarkers and does not require clinical sample preparation. The method is published in Nature Communications.
Dr Alex Ivanov, co-leader of this study from the Department of Chemistry at Imperial, said: “The detection of single molecules of biomarkers represents the ultimate in sensitivity for early diagnosis. We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.”
Binding to biomarkers
The method the team developed uses the ‘backbone’ of DNA, the structure it is built around. They grafted ‘aptamers’ – synthetic DNA molecules that bind to specific target biomarkers – to DNA backbones.
When added to human serum, the aptamers bind to biomarkers before being analysed by passing through a nanopore detector. Nanopores are miniscule holes (often as small as a few billionths of a meter) that measure a change in electrical current as molecules pass through them.
Each biomarker has a unique current signature, so the presence and concentration of target biomarkers can be analysed in this way.
With the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
– Dr Jasmine Sze
The team demonstrated that their system can work by testing three aptamers on one DNA backbone. They found that the nanopores can detect the specific biomarkers that the aptamers were designed to pick up.
They say that the system can be constructed with more than five different aptamers, allowing detection of multiple biomarkers at once. In addition, the biomarkers were detected in human serum, meaning far less preparation time and cost were needed.
Based on the preliminary findings of this study, research efforts are now focused on several types of cancer and neurological disorders, which can benefit from the detection of biomarkers that are in low abundance in clinical samples.
The team have filed a patent for the technology, and are currently exploring routes towards commercialisation so that it can be used to ultimately improve quality of life.
Dr Jasmine Sze, who completed this study as part of her PhD in the Department of Chemistry and has recently moved to the IMED Biotech at AstraZeneca said “Looking forward, with the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
“It has great potential for biomarker discovery, development of companion diagnostics as well as clinical endeavours, such as direct diagnosis, prognosis and sub-type classification with single-molecule sensitivity.”
The Latest on: Disease diagnosis
- Pediatric Patients With ASMD Show Significant Improvement in Olipudase Alfa Trialon December 4, 2021 at 8:40 am
Findings from the single-arm, open-label ASCEND-Peds trial suggest olipudase alfa is well-tolerated and may lead to clinically meaningful improvements in patients with acid sphingomyelinase deficiency ...
- Parents of Grand Forks girl fighting rare disease push for FDA approval of gene therapy that could save her lifeon December 4, 2021 at 7:31 am
At the tender age of 3, Daphne Enger, was a spunky, sassy, happy child. Then, one night in February 2019, the world as she and her family knew it turned upside down. At home, Daphne had started to ...
- Diabetes symptoms: The 12 signs of low blood sugar you should NEVER ignoreon December 4, 2021 at 6:45 am
DIABETES symptoms tend to go unnoticed for long periods of time, as you might not start feeling unusually unwell. But there are some key warning signs of low blood sugar you should never ignore.
- IVF used by some to avoid passing on genetic diseases to offspringon December 4, 2021 at 5:04 am
Some couples with muscular dystrophy, cystic fibrosis and other such ailments undergo in vitro fertilization and preimplantation genetic testing to find disease-free embryos.
- 'You're going to have a great life:' Michael J. Fox on what he wishes he had known when diagnosedon December 4, 2021 at 5:00 am
In 30 years since his diagnosis with Parkinson's disease, Fox has become an expert on the clinical aspects as well as the devastatingly personal ones.
- 1 in 44 U.S. Children Are Diagnosed with Autism, New CDC Data Suggestson December 3, 2021 at 6:54 pm
New data from the Centers for Disease Control and Prevention suggests more children in the U.S. are being diagnosed with autism at younger ages. The CDC released 2018 data on Thursday from nearly a ...
- Inmate dies of Legionnaires' disease after outbreak at Pendleton facilityon December 3, 2021 at 4:06 pm
Indiana Department of Correction officials said Wednesday an outbreak of Legionnaires' disease has been confirmed among inmates at the Pendleton Correctional Facility. In a press release, a DOC ...
- Genetic diagnosis of rare diseases up with genome sequencingon December 3, 2021 at 8:50 am
(HealthDay)—Use of genomic sequencing yields an increase in genomic diagnoses across a spectrum of rare diseases, according to a study published in the Nov. 11 issue of the New England Journal of ...
- UAB researcher shines light on a rare disease that causes developmental and intellectual delayson December 3, 2021 at 6:28 am
After years of researching the SON gene, Erin Eun-Young Ahn, Ph.D., may have found the cause behind an extremely rare disease.
- Cancer Is the Leading Cause of “Death From Disease” in Children. Here’s Why.on December 3, 2021 at 3:00 am
Agin, then a civil defense lawyer in Washington, DC, was dislodged from his comfortable life and dragged into the surreal world of a young cancer victim’s parent: The sleepless nights in the din of a ...
via Google News and Bing News